Skip to main content
HR 4895 118th Congress House Health Government information and archives Health care costs and insurance Medicare Prescription drugs

Lowering Drug Costs for American Families Act

Introduced: August 1, 2023 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jul 28, 2023
Referred to the Subcommittee on Health.
Jul 26, 2023
Introduced in House
Jul 26, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Lowering Drug Costs for American Families Act

This bill expands the Medicare Drug Price Negotiation Program to include additional drugs and drugs that are covered under private insurance. It also extends certain rebate requirements for covered drugs under Medicare to drugs that are covered under private insurance.

Current law requires the Centers for Medicare & Medicaid Services (CMS) to negotiate maximum prices for brand-name drugs that do not have other generic equivalents and that account for the greatest Medicare spending; the CMS must eventually negotiate the prices of 20 drugs that are covered under Medicare in 2029 and each year thereafter.

The bill requires the CMS to negotiate the prices of 50 drugs beginning in 2029. It also applies the negotiated maximum prices under the program to drugs that are covered under private health insurance, unless the insurer opts out. The CMS, Department of Labor, and Department of Treasury must publish a list of insurers that choose to opt out; insurers must also publicly disclose their decision to opt out.

Current law also requires drug manufacturers to issue rebates to the CMS for brand-name drugs without generic equivalents under Medicare that cost $100 or more per year per individual and for which prices increase faster than inflation. The bill extends these requirements to drugs that are covered under private insurance.

 

 

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 73
D
Stanton, Greg
Arizona · Sep 27, 2024
D
Matsui, Doris O.
California · Aug 13, 2024
D
Sherman, Brad
California · Aug 2, 2024
D
Fletcher, Lizzie
Texas · Jul 24, 2024
D
Clarke, Yvette D.
New York · Jul 22, 2024
D
Sánchez, Linda T.
California · Jun 28, 2024
D
Kaptur, Marcy
Ohio · Jun 25, 2024
Lee, Barbara
· May 21, 2024
D
Lee, Summer L.
Pennsylvania · Feb 26, 2024
D
Tokuda, Jill N.
Hawaii · Dec 5, 2023
D
Nadler, Jerrold
New York · Oct 3, 2023
Cartwright, Matt
· Sep 28, 2023
D
Davids, Sharice
Kansas · Sep 26, 2023
D
Pingree, Chellie
Maine · Sep 26, 2023
Spanberger, Abigail
· Sep 26, 2023
D
Connolly, Gerald E.
Virginia · Sep 12, 2023
D
Escobar, Veronica
Texas · Sep 12, 2023
Kildee, Daniel
· Sep 12, 2023
D
Larsen, Rick
Washington · Sep 12, 2023
Porter, Katie
· Sep 12, 2023
Caraveo, Yadira
· Aug 22, 2023
D
Salinas, Andrea
Oregon · Aug 22, 2023
D
Williams, Nikema
Georgia · Aug 22, 2023
D
Barragán, Nanette Diaz
California · Aug 15, 2023
D
DeGette, Diana
Colorado · Aug 15, 2023
D
Panetta, Jimmy
California · Aug 15, 2023
D
Balint, Becca
Vermont · Aug 8, 2023
D
DeSaulnier, Mark
California · Aug 8, 2023
D
Dingell, Debbie
Michigan · Aug 8, 2023
D
Magaziner, Seth
Rhode Island · Aug 8, 2023
Manning, Kathy
· Aug 8, 2023
D
Moore, Gwen
Wisconsin · Aug 8, 2023
D
Morelle, Joseph D.
New York · Aug 8, 2023
D
Wasserman Schultz, Debbie
Florida · Aug 8, 2023
D
Goldman, Daniel S.
New York · Aug 1, 2023
D
Grijalva, Raúl M.
Arizona · Aug 1, 2023
D
Lieu, Ted
California · Aug 1, 2023
D
McClellan, Jennifer L.
Virginia · Aug 1, 2023
D
Meng, Grace
New York · Aug 1, 2023
Sarbanes, John
· Aug 1, 2023
D
Takano, Mark
California · Aug 1, 2023
D
Beyer, Donald S.
Virginia · Jul 27, 2023
D
Bonamici, Suzanne
Oregon · Jul 27, 2023
D
Castor, Kathy
Florida · Jul 27, 2023
D
Cherfilus-McCormick, Sheila
Florida · Jul 27, 2023
D
Chu, Judy
California · Jul 27, 2023
D
Cohen, Steve
Tennessee · Jul 27, 2023
D
Courtney, Joe
Connecticut · Jul 27, 2023
D
Craig, Angie
Minnesota · Jul 27, 2023
D
Evans, Dwight
Pennsylvania · Jul 27, 2023
Page 1 of 2 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4895: Lowering Drug Costs for American Families Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4895/
MLA
"H.R. 4895: Lowering Drug Costs for American Families Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4895/.
Bluebook (legal)
H.R. 4895, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4895/.
Markdown link
[H.R. 4895: Lowering Drug Costs for American Families Act](https://openamerica.io/bill/118-HR-4895/)
Report a problem